Publication | Closed Access

Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations

Molecular DockingSelective Pi3kα InhibitorDrug TargetBiochemistryMedicinePharmacotherapyPharmacologyMd SimulationsDrug Discovery